DARK SECRETS: Organon | Rare Historical Photos

Sun Pharma plans $1 billion local debt sale for loan takeout, sources say

Sun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organon acquisition, according to Reuters. The drugmaker is expected to issue two-, three- and four-year bonds as Indian companies increasingly turn to domestic debt amid high US borrowing…

The Economic Times · Sep 29

Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bid

Rating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's proposed acquisition of US-based Organon & Co. The deal is expected to significantly bolster Sun Pharma's business position and revenue base. Organon will contribute substantially to the group's earnings after the acquisition. This…

The Economic Times · Sep 8

Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%

Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, driven by strong performance in India and its innovative medicines business despite weak US formulations sales. EBITDA rose 3% to Rs 4,418 crore.…

The Economic Times · Jul 31

5 Stocks to Buy for a Harris Presidency

The race for the White House is heating up and these five stocks are set to benefit if Kamala Harris claims victory.

Kiplinger · Sep 14, 2024

If companies don't train Gen Zers, they'll train themselves

Gen Z is having a hard time getting entry-level jobs, plus companies are hiring fewer interns.

Fortune · Aug 28, 2024

3 Cheap Small-Cap Stocks to Scoop Up on the Market Pullback

With small-cap stocks grabbing investors' attention lately, here are three discounted names with solid fundamentals to grab now, while the retracement provides a prime entry point.

Barchart · Aug 2, 2024

3 Healthcare Stocks With The Highest Yields As of June 2024

Looking for yield? Here's 3 healthcare stocks with the highest yields today.

Barchart · Jun 12, 2024

Warning over asthma drug after 500 neuropsychiatric reactions reported in young children

UK medicines regulator says information accompanying montelukast will alert users to risk of mood and behaviour changes

The Guardian - UK · May 4, 2024

Safety fears over asthma drug after young children suffer severe side effects

Campaigners call for more warnings on montelukast, after reports of night terrors, depression and other mental health events

The Guardian - UK · Mar 3, 2024

Want long-term contraception? There are more effective options than the pill. But they can be hard to find

Australians’ access to a range of contraceptive options depends on where they live and how wealthy they are. A recent parliamentary inquiry recommends ways to end this “postcode lottery” for people who want to use long-acting reversible contraception.

The Conversation · Jun 1, 2023